Complex decisions: correlates of injectable contraceptive discontinuation following HIV-1 seroconversion in an HIV prevention trial

References

• Barden, J., Speizer, I. S., Calhoun, L. M., & Corroon, M. (2018). Women’s contraceptive discontinuation and switching behavior in urban Senegal, 2010-2015. BMC Women’s Health, 18(1), 35. doi: 10.1186/s12905-018-0529-9
   PubMedGoogle Scholar
• Calvert, C., & Ronsmans, C. (2013). The contribution of HIV to pregnancy-related mortality: A systematic review and meta-analysis. AIDS, 27(10), 1631–1639. doi: 10.1097/QAD.0b013e32835fd940
   PubMed Web of Science ®Google Scholar
• Darroch, J. E., & Singh, S. (2011). Estimating unintended Pregnacies Averted by Couple-years of protection (CYP). New York: Guttmacher Institute.
   Google Scholar
• Haddad, L. B., Cwiak, C., Jamieson, D. J., Feldacker, C., Tweya, H., Hosseinipour, M., … Phiri, S. (2013a). Contraceptive adherence among HIV-infected women in Malawi: A randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate. Contraception, 88(6), 737–743. doi: 10.1016/j.contraception.2013.08.006
   PubMed Web of Science ®Google Scholar
• Haddad, L., Wall, K. M., Vwalika, B., Khu, N. H., Brill, I., Kilembe, W., … Allen, S. (2013b). Contraception discontinuation and switching among couples receiving integrated HIV and damily planning services in Lusaka, Zambia. AIDS, 27(01), S93–103. doi: 10.1097/QAD.0000000000000039
   PubMedGoogle Scholar
• Hladik, W., Stover, J., Esiru, G., Harper, M., & Tappero, J. (2009). The contribution of family planning towards the prevention of vertical HIV transmission in Uganda. PLoS One, 4(11), e7691. doi: 10.1371/journal.pone.0007691
   PubMed Web of Science ®Google Scholar
• Hoyt, M. J., Storm, D. S., Aaron, E., & Anderson, J. (2012). Preconception and contraceptive care for women living with HIV. Infectious Diseases in Obstetrics and Gynecology, 2012, Article ID 604183. doi: 10.1155/2012/604183
   PubMedGoogle Scholar
• Imbuki, K., Todd, C. S., Stibich, M. A., Shaffer, D. N., & Sinei, S. K. (2010). Factors influencing contraceptive choice and discontinuation among HIV-positive women in Kericho, Kenya. African Journal of Reproductive Health, 14(4 Spec. no.), 98–109.
   PubMedGoogle Scholar
• JMP® Pro (Version 12.0.1) [Computer software]. Cary, NC, USA: SAS Institute, Inc.
   Google Scholar
• Le Coeur, S. L., Halembokaka, G., Khlat, M., Brouard, N., Purhuence, F., M'Pelé, P., … Lallemant, M. (2005). Impact of AIDS on adult mortality: A morgue-based study in Pointe-Noire, Republic of Congo. AIDS, 19(15), 1683–1687. doi: 10.1097/01.aids.0000184926.98497.0e
   PubMed Web of Science ®Google Scholar
• Magalhães, J., Amaral, E., Giraldo, P. C., & Simoes, J. A. (2002). HIV infection in women: Impact on contraception. Contraception, 66, 87–91. doi: 10.1016/S0010-7824(02)00332-3
   PubMed Web of Science ®Google Scholar
• Maraux, B., Hamelin, C., Bajos, N., Dray-Spira, R., Spire, B., Lert, F., … Vespa2 study, g. (2015). Women living with HIV still lack highly effective contraception: Results from the ANRS VESPA2 study, France, 2011. Contraception, 92(2), 160–169. doi: 10.1016/j.contraception.2015.04.010
   PubMed Web of Science ®Google Scholar
• Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., … Team, V. S. (2015). Tenofovir-based preexposure prophylaxis for HIV infection among African women. New England Journal of Medicine, 372(6), 509–518. doi: 10.1056/NEJMoa1402269
   PubMed Web of Science ®Google Scholar
• Melaku, Y. A., & Zeleke, E. G. (2014). Contraceptive utilization and associated factors among HIV positive women on chronic follow up care in Tigray Region, Northern Ethiopia: A cross sectional study. PLoS One, 9(4), e94682. doi: 10.1371/journal.pone.0094682
   PubMed Web of Science ®Google Scholar
• Microbicides Trial Network, MTN-003. Retrieved from http://www.mtnstopshiv.org/studies/70
   Google Scholar
• Nanda, K., Morrison, C. S., Kwok, C., Byamugisha, J., Jones, L., Sriplienchan, S., … Magwali, T. (2011). Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and Thailand. Contraception, 83(6), 542–548. doi: 10.1016/j.contraception.2010.09.003
   PubMed Web of Science ®Google Scholar
• Noguchi, L. M., Richardson, B. A., Baeten, J. M., Hillier, S. L., Balkus, J. E., Marrazzo, J. M., & VOICE Study Team. (2015). Risk of HIV acquisition among women who use different types of injectable progestin contraception in South Africa: A prospective cohort study. The Lancet HIV, 2(7), e279–e287. doi: 10.1016/S2352-3018(15)00058-2
   PubMed Web of Science ®Google Scholar
• Peipert, J. F., Zhao, Q., Meints, L., Peipert, B. J., Redding, C. A., & Allsworth, J. E. (2011). Adherence to dual-method contraceptive use. Contraception, 84(3), 252–258. doi: 10.1016/j.contraception.2011.01.023
   PubMed Web of Science ®Google Scholar
• Pilcher, C. D., Tien, H. C., Eron, J. J., Jr., Vernazza, P. L., Leu, S. Y., Stewart, P. W., … Duke, U. N. C. E. A. H. I. V. C. (2004). Brief but efficient: Acute HIV infection and the sexual transmission of HIV. Journal of Infectious Diseases, 189(10), 1785–1792. doi: 10.1086/386333
   PubMed Web of Science ®Google Scholar
• Polis, C. B., Gray, R. H., Lutalo, T., Nalugoda, F., Kagaayi, J., Kigozi, G., … Wawer, M. J. (2011). Trends and correlates of hormonal contraceptive use among HIV-infected women in Rakai, Uganda, 1994–2006. Contraception, 83(6), 549–555. doi: 10.1016/j.contraception.2010.10.002
   PubMed Web of Science ®Google Scholar
• Raifman, J., Chetty, T., Tanser, F., Mutevedzi, T., Matthews, P., Herbst, K., … Barnighausen, T. (2014). Preventing unintended pregnancy and HIV Tranmission: Effects of the HIV treatment cascade on contraceptive Use and choice in rural KwaZulu-Natal. Journal of Acquired Immune Deficiency Syndromes, 67, S218–S227. doi: 10.1097/QAI.0000000000000373
   PubMed Web of Science ®Google Scholar
• Riddler, S., Husnik, M., Gorbach, P. M., Levy, L., Parikh, U., Livant, E., … Balkus, J. E. (2016). Long-term follow-up of HIV seroconverters in microbicide trials - rationale, study design, and challenges. HIV Clinical Trials, 17(5), 204–211. doi: 10.1080/15284336.2016.1212561
   PubMed Web of Science ®Google Scholar
• Riddler, S., Husnik, M., Pather, A., Palanee, T., Nair, G., Mhlanga, F., … Balkus, J. E. (2014). Long-term follow-up of HIV Seroconverters from the VOICE trial – An analysis of data from MTN-015. AIDS Research and Human Retroviruses, 30(S1), A93–A93. doi: 10.1089/aid.2014.5171.abstract
   Google Scholar
• Sangi-Haghpeykar, H., Poindexter, A. N., Bateman, L., & Ditmore, J. R. (1996). Experiences of injectable contraceptive users in an urban setting. Obstetrics & Gynecology, 88(2), 227–233. doi: 10.1016/0029-7844(96)00194-9
   PubMed Web of Science ®Google Scholar
• Singh, S., Darroch, J. E., Ashford, L. S., & Vlassof, M. (2009). Additing It Up: The Costs and Benefits of Investing in family planning and Matrnal and Newborn Health. New York: Guttmacher Institute.
   Google Scholar
• Smit, J. A., & Beksinska, M. E. (2013). Hormonal contraceptive continuation and switching in South Africa: Implications for evaluating the association of injectable hormonal contraceptive use and HIV. Journal of Acquired Immune Deficiency Syndromes, 62(3), 363–365. doi: 10.1097/QAI.0b013e31827e818a
   PubMed Web of Science ®Google Scholar
• Stifani, B. M., MacCarthy, S., Nunn, A., Benfield, N., & Dourado, I. (2018). From pill to condom, or Nothing at all: HIV diagnosis and discontinuation of highly effective Contraceptives Among women in Northeast Brazil. AIDS and Behavior, 22, 663–670. doi: 10.1007/s10461-017-1846-y
   PubMed Web of Science ®Google Scholar
• United Nations. (2017). Sustainable Development Goal 3: Ensure healthy lives and promote well-being for all at all ages. Retrieved from https://sustainabledevelopment.un.org/sdg3
   Google Scholar
• Wawer, M. J., Gray, R. H., Sewankambo, N. K., Serwadda, D., Li, X., Laeyendecker, O., … Quinn, T. C. (2005). Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. Journal of Infectious Diseases, 191(9), 1403–1409. doi: 10.1086/429411
   PubMed Web of Science ®Google Scholar
• Westfall, J. M., Main, D. S., & Barnard, L. (1996). Continuation rates among injectable contraceptive users. Family Planning Perspectives, 28(6), 275–277. doi: 10.2307/2136058
   PubMedGoogle Scholar
• World Health Organization. (2013, September 30). Fact sheet: Women’s health. Retrieved from http://www.who.int/en/news-room/fact-sheets/detail/women-s-health
   Google Scholar
• World Health Organization. (2015, September). Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization.
   Google Scholar
• World Health Organization. (2015). Strategies toward ending preventable maternal mortality (EPMM). World Health Organization. Retrieved from http://www.who.int/iris/handle/10665/153544
   Google Scholar
• Zaba, B., Calvert, C., Marston, M., Isingo, R., Nakiyingi-Miiro, J., Lutalo, T., … Ronsmans, C. (2013). Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: Secondary analyses of pooled community-based data from the network for Analysing longitudinal population-based HIV/AIDS data on Africa (ALPHA). The Lancet, 381(9879), 1763–1771. doi: 10.1016/S0140-6736(13)60803-X
   PubMed Web of Science ®Google Scholar